Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry

Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284678. Online ahead of print.

Abstract

Not available.